[Programs of immunosuppressive and anti-inflammatory treatment of primary idiopathic glomerulonephritis. I. Submicroscopic and focal segmental glomerulonephritis].
Klinger
M
M
Szewczyk
Z
Z
D000328:Adult; D002648:Child; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage*; D003524:Cyclosporins / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005921:Glomerulonephritis / Q000188:drug therapy*; D005923:Glomerulosclerosis, Focal Segmental / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007678:Kidney Glomerulus / Q000187:drug effects / Q000473:pathology; D009402:Nephrosis, Lipoid / Q000188:drug therapy* / Q000473:pathology; D011241:Prednisone / Q000008:administration & dosage*; D012074:Remission Induction
D003524:Cyclosporins; D003520:Cyclophosphamide; D011241:Prednisone
Programy leczenia immunosupresyjno-przeciwzapalnego pierwotnych, idiopatycznych kłebkowych zapaleń nerek. Cz. I. Submikroskopowe kłebkowe zapalenie nerek i ogniskowe, segmentalne szkliwienie kłebków.